Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 18/20 | 0.52 |
| ▸ | PDE1A | P54750 | 2/20 | 0.48 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.48 |
| ▸ | PDE2A | O00408 | 1/20 | 0.47 |
| ▸ | PDE8A | O60658 | 1/20 | 0.47 |
| ▸ | PDE5A | O76074 | 1/20 | 0.47 |
| ▸ | PDE9A | O76083 | 1/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.47 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.47 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2511191 | 0.92 | PDE4A (0.60) | PDE4APDE1APDE1B | |
| SCHEMBL12198227 | 0.86 | PDE4A (0.69) | PDE4APDE1APDE1BPDE2APDE8A | |
| SCHEMBL2476990 | 0.82 | PDE1A (0.64) | PDE4APDE1APDE1B | |
| SCHEMBL18927928 | 0.82 | PDE1A (0.64) | PDE4APDE1APDE1B | |
| SCHEMBL12198217 | 0.79 | PDE4A (0.82) | PDE4APDE1APDE1B | |
| SCHEMBL23082965 | 0.78 | PDE4A (0.63) | PDE4APDE1APDE1B | |
| SCHEMBL12198193 | 0.76 | PDE4A (0.85) | PDE4APDE1APDE1BPDE2APDE8A | |
| SCHEMBL16360148 | 0.76 | PDE4A (0.54) | PDE4APDE1APDE2APDE8APDE5A | |
| SCHEMBL15479041 | 0.76 | PDE4A (0.73) | PDE4APDE1BPDE2APDE8APDE5A | |
| SCHEMBL16360155 | 0.74 | PDE4A (0.53) | PDE4APDE1APDE2APDE8APDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150038474-A1 | ORGANIC COMPOUNDS | LI PENG (US) | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038474-A1 | ORGANIC COMPOUNDS | TPMT, SULT1E1, UGT2B7 | PDE4A 2122/4885PDE1A 4789/4885PDE1B 4794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.